Sexually Transmitted Disease (STD) Self-Testing Market Forecast Highlights Expansion From $1.67 Billion To $2.42 Billion Through 2030
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Sexually Transmitted Disease (STD) Self-Testing Market CAGR Analysis And Future Market Development
The market for self-testing kits targeting sexually transmitted diseases (STDs) has experienced robust expansion in recent years. Projected figures indicate it will rise from $1.52 billion in 2025 to $1.67 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.9%. This historical growth has been driven by factors such as insufficient knowledge regarding STD testing, the social stigma linked to visiting healthcare facilities, a dependence on hospital-centered diagnostics, an absence of accessible testing methods, and the increasing prevalence of sexually transmitted infections.
The sexually transmitted disease (STD) self-testing market is projected to experience significant expansion over the coming years. By 2030, its value is anticipated to reach $2.42 billion, representing a compound annual growth rate (CAGR) of 9.7%. This forecasted growth is driven by factors such as the rising use of digital health platforms, the introduction of multi-sample at-home testing kits, heightened government-led awareness initiatives, an increase in telehealth consultations, and the advancement of rapid and precise diagnostic technologies. Key trends influencing this period include a growing preference for at-home STD testing kits, greater awareness around sexual health and early detection, the expansion of telehealth and remote consultation services, the widening availability of these products through online and retail pharmacy channels, and the integration of multi-sample testing solutions that cover blood and urine samples.
Download A Free Sample Report For Comprehensive Market Insights:
Sexually Transmitted Disease (STD) Self-Testing Market Demand Drivers: What Is Fueling Industry Growth?
The growing frequency of syphilis infections is anticipated to accelerate expansion within the sexually transmitted disease (STD) self-testing market in the coming period. Syphilis, a sexually transmitted infection that manifests as bodily sores, may result in severe health complications when left untreated. Its prevalence is climbing due to reduced regular condom usage, especially among individuals involved in high-risk sexual activities. STD self-testing offers a confidential and practical method for conducting at-home syphilis screening, which facilitates earlier diagnosis. This timely identification supports immediate treatment, lessening the risk of complications and curbing further transmission. For example, in September 2025, the Centers for Disease Control and Prevention, a government agency based in the United States, reported approximately 209,253 syphilis cases in 2023, reflecting a 1% rise compared to 207,269 cases in 2022. Consequently, the increasing occurrence of syphilis is fueling growth in the STD self-testing market.
Sexually Transmitted Disease (STD) Self-Testing Market Segments: Where Are The Largest Growth Opportunities?
The sexually transmitted disease (std) self-testing market covered in this report is segmented –
1) By Sample Type: Blood Based Test, Urine Based Test, Oral Based Test
2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
3) By Application: Chlamydia trachomatis (CT) Or Neisseria gonorrhoeae (NG) Testing, Syphilis Testing, Human Immunodeficiency Virus (HIV) Testing, Other Applications
Subsegments:
1) By Blood-Based Test: Fingerstick Blood Sample, Dried Blood Spot (DBS) Sample, Capillary Blood Collection Device
2) By Urine-Based Test: First-Catch Urine Sample, Midstream Urine Sample, Preservative-Added Urine Collection
3) By Oral-Based Test: Oral Swab Sample, Oral Fluid Collection Device, Gumline Swab Collection
Sexually Transmitted Disease (STD) Self-Testing Market Innovation Trends: Which Developments Are Transforming The Industry?
Major players within the STD self-testing industry are prioritizing the creation of advanced diagnostic tools, including over-the-counter (OTC) sample collection kits, aimed at facilitating early infection detection and encouraging timely therapeutic interventions. These OTC collection kits are at-home diagnostic tools that enable individuals to obtain samples—such as urine or swabs—without requiring a medical prescription. They offer a convenient and private means of spotting infections at an early stage, thereby making quick treatment possible. As an example, iHealth Labs Inc., a digital health company based in the United States, introduced the CheckMeSafe home collection kit for HIV and syphilis testing in August 2023. This FDA-endorsed kit is designed for individuals aged 18 and older, allowing them to collect blood specimens for detecting HIV (including types I, II, and P24 antigen) and syphilis, all from the security and privacy of their own residence. Users can send their collected samples to a laboratory using a provided prepaid overnight shipping label, with confidential and dependable results delivered in as little as two days. The kit boasts exceptional accuracy, with sensitivity rates reaching 99.9% for HIV and 99.5% for syphilis. Every sample undergoes analysis in a laboratory that holds both CLIA certification and CAP accreditation, ensuring strict adherence to rigorous federal and state quality standards through routine assessments.
Sexually Transmitted Disease (STD) Self-Testing Market Major Participants And Competitive Dynamics
Major companies operating in the sexually transmitted disease (std) self-testing market are Abbott Laboratories, Viatris Inc., Hologic Inc., OraSure Technologies Inc., LifeCell International, LetsGetChecked Health Inc., Visby Medical Inc., Everlywell Inc., Guangzhou Wondfo Biotech Co. Ltd., NOWDiagnostics Inc., bioLytical Laboratories Inc., Atomo Diagnostics Limited, myLAB Box Inc., BioSure UK Ltd., JAL Medical (S) Pte Ltd., TBD Health Inc., Recombigen Laboratories Private Limited, Alpine Biomedicals Pvt. Ltd., Homed-IQ B.V., Newfoundland Diagnostics Pvt. Ltd.
Access The Complete Sexually Transmitted Disease (STD) Self-Testing Market Report:
Sexually Transmitted Disease (STD) Self-Testing Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the sexually transmitted disease (STD) self-testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted disease (std) self-testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
